Immune reconstitution in HIV-1 infected children with discordant response to antiretroviral therapies: Patterns of HIV-1 env gene evolution driven by restoration of thymic function

被引:0
作者
Vecchi, M [1 ]
Burighel, N
Bellanova, D
Menzo, S
De Rossi, A
Clementi, M
Bagnarelli, P
机构
[1] Univ Politecn Marche, Ist Microbiol & Sci Biomed, Ancona, Italy
[2] Univ Padua, Dipartimento Oncol & Sci Chirurg, Ctr Riferimento AIDS, I-35100 Padua, Italy
[3] Univ Vita Salute San Raffaele, Microbiol Lab, IRCCS, San Raffaele Sci Inst, Milan, Italy
来源
MICROBIOLOGICA | 2004年 / 27卷 / 02期
关键词
HIV-1; evolution; env; V3; recocombinant virus; thymic output;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The evolution of human immunodeficiency virus type 1 (HIV-1) envgp120 region was addressed in HIV-1 infected children showing virological failure to antiretroviral therapy (ART). Sequence analysis of the replicating plasma virus at baseline and after one year of therapy documented evolution of gp120 in all subjects but one. Analysis of the hosts selective pressure showed that the values of Ka/Ks ratios were higher in the V3 sequence than in the whole C2-V5 region in 4 of 5 children with improvement of thymic output. Moreover; in 2 of the 4 children, the V3 evolution paralleled with a reverse shift of the viral phenotype (from CXCR4-tropic to CCR5-tropic). These results suggest that, under ART the V3 evolution towards less pathogenic viral variants may be driven by the hosts increased selective pressure following restoration of thymic function and immune reconstitution.
引用
收藏
页码:99 / 104
页数:6
相关论文
共 16 条
[1]   Host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution [J].
Bagnarelli, P ;
Mazzola, F ;
Menzo, S ;
Montroni, M ;
Butini, L ;
Clementi, M .
JOURNAL OF VIROLOGY, 1999, 73 (05) :3764-3777
[2]   Analysis of the functional relationship between V3 loop and gp120 context with regard to human immunodeficiency virus coreceptor usage using naturally selected sequences and different viral backbones [J].
Bagnarelli, P ;
Fiorelli, L ;
Vecchi, M ;
Monachetti, A ;
Menzo, S ;
Clementi, M .
VIROLOGY, 2003, 307 (02) :328-340
[3]   Evaluation of T cell receptor gene rearrangement excision circles after antiretroviral therapy in children infected with human immunodeficiency virus [J].
Chavan, S ;
Bennuri, B ;
Kharbanda, M ;
Chandrasekaran, A ;
Bakshi, S ;
Pahwa, S .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (10) :1445-1454
[4]   The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection [J].
Cocchi, F ;
DeVico, AL ;
GarzinoDemo, A ;
Cara, A ;
Gallo, RC ;
Lusso, P .
NATURE MEDICINE, 1996, 2 (11) :1244-1247
[5]   Change in coreceptor use correlates with disease progression in HIV-1-infected individuals [J].
Connor, RI ;
Sheridan, KE ;
Ceradini, D ;
Choe, S ;
Landau, NR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :621-628
[6]   Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial [J].
De Rossi, A ;
Walker, AS ;
Klein, N ;
De Forni, D ;
King, D ;
Gibb, DM .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (03) :312-320
[7]   Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapy [J].
Frost, SDW ;
Günthard, HF ;
Wong, JK ;
Havlir, D ;
Richman, DD ;
Brown, AJL .
VIROLOGY, 2001, 284 (02) :250-258
[8]  
Jensen Mark A., 2003, AIDS Reviews, V5, P104
[9]   Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: Virus fitness in the absence and in the presence of drug [J].
Mammano, F ;
Trouplin, V ;
Zennou, V ;
Clavel, F .
JOURNAL OF VIROLOGY, 2000, 74 (18) :8524-8531
[10]   Processivity and drug-dependence of HIV-1 protease: determinants of viral fitness in variants resistant to protease inhibitors [J].
Menzo, S ;
Monachetti, A ;
Balotta, C ;
Corvasce, S ;
Rusconi, S ;
Paolucci, S ;
Baldanti, F ;
Bagnarelli, P ;
Clementi, M .
AIDS, 2003, 17 (05) :663-671